Details
- ●Title: General Partner
- ●Expertise areas: bio+health, engineering biology, genomics, AI drug discovery
- ●Recent focus: Investing in AI-native biotech and engineering biology platforms
Key considerations
- ●bio+health: Active publication + talk activity in the last 12 months
- ●engineering biology: Active publication + talk activity in the last 12 months
- ●genomics: Active publication + talk activity in the last 12 months
Source: Institution profile, PubMed, LinkedIn, conference programs · biotech.today analysis (Apr 2026)